Skip to content

Abbott ABT Medical Devices — Total Assets

Other segment segments

Diagnostic Products
$9.63B+22.8%
Nutritional Products
$4.9B+5.8%
Established Pharmaceuticals
$3.67B+6.3%

Similar metrics at other companies

Asset Entities logo
ASSTMedical Device — Total Assets
$17.63M
InfuSystem Holdings logo
INFUDevice Solutions — Total Assets
$45.75M-5.4%
Johnson & Johnson logo
JNJMedical Devices — Total Assets
$86.58B-0.2%
Knowles logo
KNMedTech & Specialty Audio — Total Assets
$388.5M-2.0%
Emerson Electric logo
EMRIntelligent Devices — Total Assets
$11.96B
Medtronic logo
MDTOther Operating Segments, Including Diabetes — Total Assets
$4.83B+8.9%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$179.51B-18.3%
Enterprise value$206.76B-13.1%
P/E33.1×+17.4×
P/S3.9×-1.2×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's medical devices — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's medical devices — total assets?
Abbott (ABT) reported medical devices — total assets of $10.98B in Q1 2026.
How has Abbott's medical devices — total assets changed year-over-year?
Abbott's medical devices — total assets increased by 9.5% year-over-year, from $10.03B to $10.98B.
What does medical devices — total assets mean?
This metric represents the total economic resources controlled by the medical devices business segment, including property, plant, equipment, and intangible assets dedicated to the development and manufacturing of cardiovascular, diabetes, and neuromodulation technologies. It reflects the capital intensity required to support the segment's innovation pipeline and global supply chain operations. Tracking this asset base helps investors understand the scale of infrastructure and intellectual property deployed to sustain the segment's market position.